| Chemical | Toxicity Endpoint Type | Endpoint Description | Endpoint Value | Sample Size | Life Cycle Stage | Study Duration | Type |
|---|---|---|---|---|---|---|---|
| LEAD (elemental) | TOX-Non-Repro-Sublethal - cellular/biochemical effects | hematocrit | 31% decrease at 625 mg/kg bw 14% decrease at 125 mg/kg bw |
10/group | Nestling | 10 d | Toxicity Factor Datasets |
| LEAD (elemental) | TOX-Non-Repro-Sublethal - cellular/biochemical effects | red blood cell hemoglobin content | 48% decrease at 625 mg/kg bw 27% decrease at 125 mg/kg bw 12% decrease at 25 mg/kg bw |
10/group | Nestling | 10 d | Toxicity Factor Datasets |
| LEAD (elemental) | TOX-Non-Repro-Sublethal - cellular/biochemical effects | red blood cell delta aminolevulinic acid dehydratase | decrease at all doses (45-59%) | 10/group | Nestling | 10 d | Toxicity Factor Datasets |
| LEAD (elemental) | TOX-Non-Repro-Sublethal - cellular/biochemical effects | plasma creatine phosphokinase | 30% decrease at 625 mg/kg bw 25% decrease at 125 mg/kg bw |
10/group | Nestling | 10 d | Toxicity Factor Datasets |
| LEAD (elemental) | TOX-Non-Repro-Sublethal - cellular/biochemical effects | brain delta aminolevulinic acid dehydratase activity | decrease at 125, 625 mg/kg bw (47-57%) | 10/group | Nestling | 10 d | Toxicity Factor Datasets |
| LEAD (elemental) | TOX-Non-Repro-Sublethal - cellular/biochemical effects | kidney delta aminolevulinic acid dehydratase activity | decrease at 125, 625 mg/kg bw (71-79%) | 10/group | Nestling | 10 d | Toxicity Factor Datasets |
| LEAD (elemental) | TOX-Non-Repro-Sublethal - cellular/biochemical effects | liver delta aminolevulinic acid dehydratase activity | decrease at 125, 625 mg/kg bw (20-25%) | 10/group | Nestling | 10 d | Toxicity Factor Datasets |
